Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mellor

Showing results (171-180 of 229) with videos related to

Pageof 23
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2012
Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenaseBuvana Ravishankar, Haiyun Liu, Rahul Shinde, et al.
Cancer Research|January 9, 2015
β-catenin promotes regulatory T-cell responses in tumors by inducing vitamin A metabolism in dendritic cellsYuan Hong, Indumathi Manoharan, Amol Suryawanshi, et al.
Blood|April 28, 2007
Role of CD28 in fatal autoimmune disorder in scurfy miceNagendra Singh, Phillip R Chandler, Yoichi Seki, et al.
The Journal of Infectious Diseases|December 20, 2005
Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumoniaKoenraad F van der Sluijs, Monique Nijhuis, Johannes H M Levels, et al.
Immunity|December 15, 2010
Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive miceMadhav D Sharma, De-Yan Hou, Babak Baban, et al.
The Journal of Clinical Investigation|August 22, 2007
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenaseMadhav D Sharma, Babak Baban, Phillip Chandler, et al.
Oncogene|November 21, 2007
A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenaseT Banerjee, J B Duhadaway, P Gaspari, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Motor impairment and adaptation in a novel non-human primate model of internal capsule infarctSiddharth S Sivakumar, Shashank A Anand, Luke Brawer, et al.
Cancer Research|November 10, 2017
IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer PatientsWeili Wang, Lei Huang, Jian-Yue Jin, et al.
Molecular and Cellular Endocrinology|April 23, 2003
Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosisElspeth J Gold, Richard J B Francis, Arthur Zimmermann, et al.
Pageof 23

Showing results (171-180 of 229) with videos related to

Sort By:
Pageof 23
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2012
Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenaseBuvana Ravishankar, Haiyun Liu, Rahul Shinde, et al.
Cancer Research|January 9, 2015
β-catenin promotes regulatory T-cell responses in tumors by inducing vitamin A metabolism in dendritic cellsYuan Hong, Indumathi Manoharan, Amol Suryawanshi, et al.
Blood|April 28, 2007
Role of CD28 in fatal autoimmune disorder in scurfy miceNagendra Singh, Phillip R Chandler, Yoichi Seki, et al.
The Journal of Infectious Diseases|December 20, 2005
Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumoniaKoenraad F van der Sluijs, Monique Nijhuis, Johannes H M Levels, et al.
Immunity|December 15, 2010
Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive miceMadhav D Sharma, De-Yan Hou, Babak Baban, et al.
The Journal of Clinical Investigation|August 22, 2007
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenaseMadhav D Sharma, Babak Baban, Phillip Chandler, et al.
Oncogene|November 21, 2007
A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenaseT Banerjee, J B Duhadaway, P Gaspari, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Motor impairment and adaptation in a novel non-human primate model of internal capsule infarctSiddharth S Sivakumar, Shashank A Anand, Luke Brawer, et al.
Cancer Research|November 10, 2017
IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer PatientsWeili Wang, Lei Huang, Jian-Yue Jin, et al.
Molecular and Cellular Endocrinology|April 23, 2003
Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosisElspeth J Gold, Richard J B Francis, Arthur Zimmermann, et al.
Pageof 23